What’s the difference between Crestor and Lipitor?
Crestor and Lipitor are both brand names for statin drugs used to lower LDL (“bad” cholesterol) and reduce cardiovascular risk.
- Crestor is rosuvastatin.
- Lipitor is atorvastatin.
Both drugs work by inhibiting HMG-CoA reductase, which lowers cholesterol production in the liver.
How do their cholesterol-lowering strengths compare?
Across dose ranges, rosuvastatin and atorvastatin are both considered high-potency statins, but they’re not interchangeable milligram-for-milligram. Patients typically get titrated based on LDL response and tolerability rather than a strict conversion.
If you’re comparing them for a specific goal (for example, getting LDL under a certain threshold), the practical approach is to use the clinician’s starting dose and then adjust based on follow-up lipid panels.
Which one is usually chosen first?
Clinicians often choose between them based on:
- The target LDL reduction and expected intensity needed
- Prior statin response (or side effects)
- Drug-drug interactions and patient risk factors
- Insurance coverage and formulary preferences (generic availability varies by location and brand)
In practice, both are commonly used as first-line or “step-up” statins, with selection driven more by patient-specific factors and dosing strategy than by one being universally superior.
Are they both affected by the same side effects?
Common statin side effects apply to both:
- Muscle symptoms (myalgia is most often reported)
- Mild increases in liver enzymes (serious liver injury is rare)
- GI effects in some patients
Patients who develop muscle symptoms sometimes switch to a different statin (like switching from one to the other) or lower the dose, depending on severity.
Can patients switch between Crestor and Lipitor safely?
Switching is common when:
- LDL isn’t reduced enough at tolerated dose
- Side effects occur
- A drug becomes unavailable or insurance coverage changes
The switch usually includes a planned dose change and repeat labs to confirm LDL response, and to monitor for recurrence of side effects.
How do generic and patent issues matter for cost?
Because these are widely used statins, generics are often available, and pricing differences are frequently driven by the specific formulation and local insurance coverage. Patent or exclusivity timing can matter mainly for brand pricing and certain formulations.
For up-to-date patent and exclusivity tracking by product, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/